GLP-1 Drugs Like Ozempic Linked to Reduced Risk of Serious Infections Including TB
GLP-1 receptor agonist drugs, including popular medications like Ozempic, are showing a potential association with lower rates of serious infections, including tuberculosis. Researchers have begun linking these widely used diabetes and weight-loss drugs to unexpected immune-related benefits beyond their primary metabolic effects. The findings suggest GLP-1 drugs may have broader health implications than previously understood. Scientists are investigating the mechanisms behind this possible protective effect, though the research is still in early stages.
This is an AI-generated summary. ShortSingh links to the original source for the complete article.
Discussion (0)
Log in to join the discussion and vote.
Log in